Health4 weeks ago
Mineralys Therapeutics Soars as FDA Greenlights Blood Pressure Drug
Mineralys Therapeutics (MLYS) experienced a significant surge in its stock value on October 3, 2023, following the U.S. Food and Drug Administration’s (FDA) acceptance of a...
